Novozymes, the world’s largest producer of industrial enzymes, is upbeat on growth opportunities in China.
The Denmark-based biotech giant will increase investment in China, including in production and customer-facing activities, as the company’s local business grows, according to Peder Holk Nielsen, president and chief executive officer of Novozymes, during a trip to Beijing Monday.
With a 48 percent market share in industrial enzymes, Novozymes provide biological solutions for producers of ethanol, bread, detergent and textiles in 130 countries.
In the first half of 2017, Novozymes posted better-than-expected financial results, with its China market being “a positive surprise,” according to Nielsen.
In his eyes, huge changes have taken place in China in the past two decades, and so has the company’s business here.
“Compared with over 20 years ago, when there were hardly any cars in Beijing and few high rises on the northeastern third ring road, Novozymes’ business in China is much larger and matters more today,” Nielsen said in an interview. “Any strategy that goes on in Novozymes today will have an element of China to it, which was not the case 20 years ago, simply because the opportunities in China are so large and impressive.”
“The main growth opportunities in China are in sectors like household care, including laundry and cleaning products, as well as food and beverage, as China’s shift from a global manufacturing center to a domestic consumption-led economy means more demand for such products,” Nielsen said. “China’s detergent market is growing very fast, both liquids and powders. That’s something we take interest in.”
He believes that ethanol fuel is another market area to watch, and that despite currently being a small player in the biofuel market, China will hopefully become a much bigger market with its large fleet of cars, significant gasoline consumption and recent plans to expand ethanol fuel use.
The government last week announced a plan to push nationwide use of bioethanol gasoline by 2020 to cut emissions and fossil fuel consumption.
“The 2020 ethanol plan for China is exciting for Novozymes. It’s also exciting for the world,” Nielsen said. “It needs to get off the paper and become something that’s real.”
“The country’s quest for sustainable solutions not only creates opportunities for Novozymes but also is changing businesses all over the world, because the Chinese market is a large driving force of growth for many foreign companies,” he said.
Meanwhile, he expected to see better practice of rules in protection of intellectual property rights, though there has been improvement in this field.
With over 1,000 employees in China, Novozymes has grown from a single office in Beijing in the early 1990s to a network of research and development, production, sales and marketing in six Chinese cities.
CF Industries Holdings, Inc. (NYSE: CF) today announced that it has closed its acquisition of Incitec Pivot Limited’s (“IPL”) ammonia production complex located in Waggaman, Louisiana. Under the terms of the agreement, CF Industries purchased the Waggaman ammonia plant and related assets for $1.675 billion, subject to adjustments.
The Virgin Atlantic flight was powered entirely by SAF, that was a drop-in replacement for conventional jet fuel, but made solely from sustainable feedstocks. This was enabled through the inclusion of a new bio-based aromatic jet fuel blending component.
Cepsa SA (Madrid) has agreed a deal with C2X, an independent firm owned by AP Moller Holding with AP Moller-Maersk as minority owner, to develop a 300,000 metric tons per year renewable methanol plant at Huelva, Spain.